Managed Care

 

New Cholesterol Guidelines Could Mean Higher Premiums

MANAGED CARE June 2001. © MediMedia USA
News and Commentary

New Cholesterol Guidelines Could Mean Higher Premiums

MANAGED CARE June 2001. ©MediMedia USA

A jump in sales of cholesterol-reducing drugs could accompany the National Cholesterol Education Program's new practice guidelines on management of hypercholesterolemia — an expense that health plans are likely to pass on to subscribers.

The NCEP calls for more aggressive LDL-lowering treatment, setting targets that it says could reduce short-term risk of heart disease by 40 percent.

Among its suggestions: that the number of Americans on cholesterol-reducing drugs be tripled, to 36 million. Analysts say this could boost sales 20 percent a year for many years to come — a development that health plans are likely to digest by raising premiums. Depending on how purchasers blunt that, possibly through benefit design for this class of drugs, an important policy debate about access may be brewing.

Meetings

2014 Annual HEDIS® and Star Ratings Symposium Nashville, TN November 3–4, 2014
PCMH & Shared Savings ACO Leadership Summit Nashville, TN November 3–4, 2014
Medicare Risk Adjustment, Revenue Management, & Star Ratings Fort Lauderdale, FL November 12–14, 2014
World Orphan Drug Congress Europe 2014 Brussels, Belgium November 12–14, 2014
Healthcare Chief Medical Officer Forum Alexandria, VA November 13–14, 2014
Home Care Leadership Summit Atlanta, GA November 17–18, 2014
6th Semi-Annual Diagnostic Coverage and Reimbursement Conference Boston December 4–5, 2014
Customer Analytics & Engagement in Health Insurance Chicago December 4–5, 2014
Pharmaceutical and Biotech Clinical Quality Assurance Conference Alexandria, VA December 4–5, 2014
9th Semi-Annual Medical Device Coverage and Reimbursement Conference San Diego December 5, 2014
8th Annual Medical Device Clinical Trials Conference Chicago December 8–9, 2014
HealthIMPACT Southeast Tampa, FL January 23, 2015